IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
Recruiting
Observational Study
Gastrointestinal Motility Disorder
Gastroparesis
Neuropathy
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- University of Louisville · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with the symptoms of generalized GI dysmotility, including gastroparesis, are sometimes refractory to available medications, devices and other interventions/ Some of these patients have serologic and/or endo organ abnormalities and findings consistent with autoimmune neuropathies, primarily involving the GI tract. These disorders have been known as autoimmune gastrointestinal neuropathies…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: Patient with otherwise refractory symptoms of gastrointestinal (GI) motor disorders.
\-
Exclusion Criteria: Inability to receive intravenous immunoglobulin.
\-
Contacts